Learning Objectives
At the end of this session, you should be able to:
Understand the classification of analgesics
Explain the mechanisms of action
Know the clinical uses, side effects, and correct dosages of commonly used analgesics
Understand the role of multimodal analgesia
Analgesia is the relief of pain without loss of consciousness. It can be:
Central (acting in the brain/spinal cord)
Peripheral (acting at the site of injury or in the nerves)
Paracetamol
Non-steroidal anti-inflammatory drugs (NSAIDs): ibuprofen, diclofenac, ketorolac
Weak opioids: codeine, tramadol
Strong opioids: morphine, fentanyl, pethidine
Ketamine (at sub-anaesthetic doses)
Gabapentin, pregabalin (for neuropathic pain)
Antidepressants (e.g., amitriptyline)
Lignocaine
Bupivacaine (used in infiltration, blocks, epidurals)
Centrally acting, inhibits prostaglandin synthesis in the CNS
Weak anti-inflammatory activity
Excellent safety profile if not overdosed
Dosage:
Adults: 1 g PO/IV every 6 hours (max 4 g/day)
Children: 15 mg/kg every 6 hours
Side Effects:
Generally well tolerated
Hepatotoxicity in overdose (liver failure risk at >7.5 g in adults)
Antidote in overdose:
N-acetylcysteine (NAC)
Examples:
Ibuprofen, Diclofenac, Ketorolac, Aspirin, Indomethacin
Mechanism:
Inhibit cyclo-oxygenase (COX-1 and COX-2) enzymes
↓ Prostaglandins → ↓ inflammation, pain, and fever
Dosage:
Ibuprofen: 400–600 mg PO every 6–8 hours (max 2.4 g/day)
Diclofenac: 50 mg PO every 8 hours or 75 mg IM
Ketorolac: 30 mg IV/IM every 6 hours (max 120 mg/day; limit use to ≤5 days)
Side Effects:
Gastritis, GI bleeding
Renal impairment
Bronchospasm (esp. in asthmatics)
Platelet dysfunction
Contraindications:
Peptic ulcer disease
Renal failure
Bleeding disorders
Asthma (with caution)
Third trimester of pregnancy
Opioids bind to mu (μ), delta (δ), and kappa (κ) receptors in the CNS to inhibit pain perception.
Codeine: 30–60 mg PO every 4–6 hours (ceiling effect at 240 mg/day)
Tramadol: 50–100 mg PO/IV every 6–8 hours (max 400 mg/day)
Also inhibits serotonin and norepinephrine reuptake
Morphine
Prototype opioid
For moderate to severe pain
Metabolised in the liver, excreted by kidneys
Dosage:
IV: 2–10 mg every 2–4 hours
SC/IM: 5–15 mg every 4 hours
PO (slow release): 10–30 mg every 12 hours
Side Effects:
Respiratory depression
Sedation
Nausea and vomiting
Constipation
Urinary retention
Pruritus
Hypotension (especially IV)
Antidote:
Naloxone (opioid antagonist): 0.4–2 mg IV every 2–3 minutes PRN, up to 10 mg
Fentanyl
Synthetic opioid, 100 times more potent than morphine
Very lipid-soluble → rapid onset and short duration
Dosage:
IV: 25–100 mcg every 30–60 minutes
Also available as transdermal patch (not for acute use)
Uses:
Intraoperative analgesia
Postoperative pain
Sedation in ICU
Advantages:
Minimal histamine release
Better cardiovascular stability than morphine
Disadvantages:
Respiratory depression
Short duration unless given by infusion or patch
Pethidine (Meperidine)
Not preferred anymore due to neurotoxicity
Metabolite: norpethidine → seizures in renal failure
Dosage:
50–100 mg IM/IV every 4 hours
Side Effects:
Seizures
Less constipation than morphine
Definition:
Combining analgesics from different classes to improve pain control and reduce opioid use.
Paracetamol + NSAID + Opioid (as needed)
+/- regional block or spinal analgesia
Synergistic pain control
Lower opioid doses needed
Fewer side effects (e.g., less respiratory depression)
MORE ON MORPHINE
Morphine dose depends on the route of administration and the clinical context. Here are typical dosing guidelines:
Analgesia (pain relief): 0.1 mg/kg IV every 2–4 hours as needed.
Titration for severe pain: Start with 2–5 mg IV, increasing as required.
Continuous infusion: 0.5–2 mg/hour IV for sustained pain management.
Typical dose: 5–10 mg IM every 4 hours.
Standard dose: 5–10 mg SC every 4–6 hours.
Immediate-release: 10–30 mg PO every 4 hours.
Extended-release: 15–200 mg PO every 12–24 hours (dose adjusted based on pain control needs).
Renal impairment: Reduce the dose to prevent accumulation and toxicity.
Opioid-naïve patients: Start with the lowest effective dose to minimize respiratory depression risk.